US
US Hyperbaric Oxygen Therapy Market Industry Trends and Forecast to 2034: Segmented by (Product, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
US · 2024–2034 · estimates
Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
US (this report) at $1.61 Bn.
Canada at 6.4% a year.Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$740.8 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $1.54 Bn | — | — |
| 2025 (base) | $1.61 Bn | +$66.3 Mn | — |
| 2026 (forecast) | $1.68 Bn | +$69.1 Mn | +4.3% |
| 2027 (forecast) | $1.75 Bn | +$72.1 Mn | +8.8% |
| 2028 (forecast) | $1.82 Bn | +$75.2 Mn | +13.5% |
| 2029 (forecast) | $1.90 Bn | +$78.5 Mn | +18.3% |
| 2030 (forecast) | $1.98 Bn | +$81.8 Mn | +23.4% |
| 2031 (forecast) | $2.07 Bn | +$85.3 Mn | +28.7% |
| 2032 (forecast) | $2.16 Bn | +$89.0 Mn | +34.3% |
| 2033 (forecast) | $2.25 Bn | +$92.8 Mn | +40% |
| 2034 (forecast) | $2.35 Bn | +$96.8 Mn | +46.1% |
Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
US (this report)
$1.61 Bn
Canada
$305.3 Mn
China
$284.8 Mn
Japan
$218.8 Mn
Germany
$142.5 Mn
France
$113.9 Mn
UK
$108.6 Mn
Italy
$100.3 Mn
Brazil
$91.5 Mn
Ecuador
$82.6 Mn
Saudi Arabia
$77.6 Mn
India
$78.8 Mn
Spain
$68.2 Mn
Mexico
$57.3 Mn
Australia
$46.5 Mn
New Zealand
$44.8 Mn
Russia
$42.9 Mn
South Africa
$22.9 Mn
UAE
$20.0 Mn
Egypt
$12.9 Mn
Philippines
$7.5 Mn
Hong Kong
$5.9 Mn
Malaysia
$5.4 Mn
Thailand
$5.2 Mn
Singapore
$5.1 Mn
Kenya
$2.9 Mn
Hyperbaric oxygen therapy has patients breathe pure oxygen in a pressurised chamber to help wounds heal and treat certain conditions.
Key segments of the hyperbaric Oxygen Therapy market include product (Monoplace Chambers, Multiplace Chambers and Portable Chambers) and application (Wound Healing, Decompression Sickness and Wellness and Longevity).
An ageing population, longer life expectancy, rising interest in healthy ageing and new science on how the body ages are driving the hyperbaric Oxygen Therapy market. Older adults and their families are spending more on staying active and independent.
Preventive care, personalised plans based on biomarkers and home-based services give the hyperbaric Oxygen Therapy market room to grow, especially in fast-ageing countries in Asia and Europe.
Limited clinical proof for some longevity products, high out-of-pocket costs, regulation that does not treat ageing as a disease and uneven access hold back the hyperbaric Oxygen Therapy market.
The hyperbaric Oxygen Therapy market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how hyperbaric Oxygen Therapy products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in US.
What doctors and scientists are doing in Hyperbaric Oxygen Therapy right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
Pharmaceuticals · US
Healthcare Services · US
Pharmaceuticals · US
Pharmaceuticals · US
Healthcare Services · US
Healthcare Services · US